Whole Plant Medicine Is the Future
September 1st 2021Cannabis’s biggest antagonist is the stigma that surrounds it. Whole plant medicine has the potential to significantly benefit the pharmaceutical industry by complementing their efforts to bring patients relief from their ailments. Systems dynamics consultant/researcher, Ruth Fisher, PhD, explains how cannabis has the option to flourish but needs to stop having its efforts for growth and research hampered by opinions.
Medical Cannabis and Caregiver Rights in Hawaii
August 31st 2021At a young age, Jari Sugano’s daughter, MJ, was diagnosed with Dravet syndrome. Standard pharmaceuticals didn’t help in alleviating her daughter's seizures. Here, Sugano talks about how medical cannabis has helped MJ and the importance of the caregiver role.
Holistic Health Alternatives Offer Patients Other Treatment Plans
August 25th 2021Pepper Hernandez, a doctor of naturopathic medicine, board-certified holistic health practitioner, PhD in transpersonal psychology, and the CEO and founder of the Cannabis Holistic Institute, shares her experiences as a medical cannabis patient turned educator.
The Serious THC Problem in the US
July 28th 2021A recent article published by FiveThirtyEight (1) was highlighted on major news networks across the US, bringing attention to a very important issue facing the cannabis industry: how much tetrahydrocannabinol (THC) is actually in products. Here, we highlight some of the findings from the FiveThirtyEight report and what it means for the cannabis industry.
Neuropathix, Inc.’s CBD Chemotherapy Study Published in British Journal of Pharmacology
May 24th 2021British Journal of Pharmacology published a study' findings that highlighted the ability of Neuropathix’s patented compound KLS-13019 to prevent and reverse chemotherapy-induced peripheral neuropathy (CIPN) in mice.